Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.J Med Chem. 2006 Nov 30; 49(24):7239-41.JM
Abstract
A successful virtual screening experiment of novel SIRT2 inhibitors is described. Four out of 11 experimentally tested compounds showed in vitro inhibitory activity toward SIRT2 in a micromolar level, resulting in an experimental hit ratio of 36%. Two of these compounds inhibited SIRT2 with IC50 (microM) values of 51 and 91; moreover, one of the new inhibitors was comprised of an entirely new SIRT2-inhibiting structural scaffold.
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
17125277
Citation
Tervo, Anu J., et al. "Discovering Inhibitors of Human Sirtuin Type 2: Novel Structural Scaffolds." Journal of Medicinal Chemistry, vol. 49, no. 24, 2006, pp. 7239-41.
Tervo AJ, Suuronen T, Kyrylenko S, et al. Discovering inhibitors of human sirtuin type 2: novel structural scaffolds. J Med Chem. 2006;49(24):7239-41.
Tervo, A. J., Suuronen, T., Kyrylenko, S., Kuusisto, E., Kiviranta, P. H., Salminen, A., Leppänen, J., & Poso, A. (2006). Discovering inhibitors of human sirtuin type 2: novel structural scaffolds. Journal of Medicinal Chemistry, 49(24), 7239-41.
Tervo AJ, et al. Discovering Inhibitors of Human Sirtuin Type 2: Novel Structural Scaffolds. J Med Chem. 2006 Nov 30;49(24):7239-41. PubMed PMID: 17125277.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.
AU - Tervo,Anu J,
AU - Suuronen,Tiina,
AU - Kyrylenko,Sergiy,
AU - Kuusisto,Erkki,
AU - Kiviranta,Päivi H,
AU - Salminen,Antero,
AU - Leppänen,Jukka,
AU - Poso,Antti,
PY - 2006/11/28/pubmed
PY - 2007/2/16/medline
PY - 2006/11/28/entrez
SP - 7239
EP - 41
JF - Journal of medicinal chemistry
JO - J Med Chem
VL - 49
IS - 24
N2 - A successful virtual screening experiment of novel SIRT2 inhibitors is described. Four out of 11 experimentally tested compounds showed in vitro inhibitory activity toward SIRT2 in a micromolar level, resulting in an experimental hit ratio of 36%. Two of these compounds inhibited SIRT2 with IC50 (microM) values of 51 and 91; moreover, one of the new inhibitors was comprised of an entirely new SIRT2-inhibiting structural scaffold.
SN - 0022-2623
UR - https://www.unboundmedicine.com/medline/citation/17125277/Discovering_inhibitors_of_human_sirtuin_type_2:_novel_structural_scaffolds_
L2 - https://doi.org/10.1021/jm060686r
DB - PRIME
DP - Unbound Medicine
ER -